As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs have transformed the way we think about our bodies, weight loss ... “Giving myself a weekly injection sounded ...

In recent years, GLP-1 for weight loss has emerged as a significant breakthrough, capturing the attention of both healthcare providers and individuals struggling with obesity. Glucagon-like peptide-1 ...

Weight loss drugs have surged in popularity. But Gov. Ned Lamont wants CT’s Medicaid program to discontinue covering them for ...

While popular GLP-1 drugs require daily or weekly injections ... While GLP-1 drugs are popular for helping users lose weight quickly, they can also have an unfortunate side effect: muscle loss.

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Allurion Technologies' gastric balloon and Novo Nordisk's semaglutide achieved 20.3% weight loss in a trial. Read more here.

Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk is seen on Oct. 16, 2024. James Manning/PA Images via Getty Images, FILE Narula said people currently ...

Most major weight-loss drugs are delivered by weekly injections, including Zepbound, Wegovy, and Ozempic. Novo Nordisk is also working on a GLP-1 weight-loss pill. Last, year the company said that ...

GLP-1 receptor agonists are transforming the landscape of medical weight loss, yet many individuals experience nutrient deficiencies and side effects such as nausea and appetite suppression.